GSK Set To Compete Against Pfizer In Pentavalent Meningococcal Vaccination, But When?
Executive Summary
The company presented data for its MenABCWY vaccine, but it still hasn’t specified the timing for approval. While its launch would lag Pfizer’s, GSK has an advantage in terms of data as well as leadership in the space.